Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 17
Phase 26

Trial Status

Completed2
Recruiting1
Terminated3
Other7

Role Distribution

Principal Investigator13
PI Rate100%

Activity Timeline

Clinical Trials (13)

NCT07113743Phase 1/2Enrolling By Invitation
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Chronic Granulomatous Disease (CGD)
PrincipalinvestigatorStart date: 2025-09-10
NCT06253507Phase 1/2Enrolling By Invitation
pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
Autosomal RecessiveChronic Granulomatous Diseasep47
PrincipalinvestigatorStart date: 2024-06-25
NCT05600907Early Phase 1Active Not Recruiting
Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)
CGDChronic Granulomatous Disease
PrincipalinvestigatorStart date: 2023-01-02
NCT01123499Terminated
Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers
Normal Physiology
PrincipalinvestigatorStart date: 2016-10-06
NCT02629120Phase 1/2Active Not Recruiting
High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
Chronic Granulomatous Disease Transplant
PrincipalinvestigatorStart date: 2015-12-17
NCT02116764Completed
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
Chronic Granulomatous Disease
PrincipalinvestigatorStart date: 2014-06-11
NCT01851460Phase 1Withdrawn
Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease
Chronic Granulomatous Diseases (CGD) and Liver Lesions
PrincipalinvestigatorStart date: 2013-05-08

Showing 10 of 13 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

K. Scott Baker

Fairview University Medical Center

Related
3 trials

Shared therapeutic areas:

Granulomatous Disease, ChronicSevere Combined Immunodeficiency
Similarity Score7%

Christa S Zerbe, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
8 trials

Shared therapeutic areas:

Granulomatous Disease, ChronicNormal Physiology

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score7%

Tanya J Lehky, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
4 trials

Shared therapeutic areas:

Normal Physiology
Similarity Score3%

Miroslav Backonja, M.D.

National Center for Complementary and Integrative Health (NCCIH)

Related
5 trials

Shared therapeutic areas:

Normal Physiology
Similarity Score3%

Leonardo G Cohen, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
14 trials

Shared therapeutic areas:

Normal Physiology
Similarity Score3%

Thorsten Kahnt, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
5 trials

Shared therapeutic areas:

Normal Physiology
Similarity Score3%

Robert N Hoover, M.D.

National Cancer Institute (NCI)

Related
3 trials

Shared therapeutic areas:

Normal Physiology
Similarity Score3%

Ian A Myles, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
6 trials

Shared therapeutic areas:

Granulomatous Disease, Chronic

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score3%

Robert Krance, MD

Baylor College of Medicine

Related
5 trials

Shared therapeutic areas:

Granulomatous Disease, Chronic
Similarity Score3%

Kong Y Chen, Ph.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Normal Physiology
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT04370795Phase 1/2PrincipalInvestigator

Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus

Severe Combined Immune Deficiency (SCID)
Withdrawn
NCT07113743Phase 1/2PrincipalInvestigator

Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

Chronic Granulomatous Disease (CGD)
Enrolling By Invitation
NCT06253507Phase 1/2PrincipalInvestigator

pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

Autosomal RecessiveChronic Granulomatous Diseasep47
Enrolling By Invitation
NCT05600907Early Phase 1PrincipalInvestigator

Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

CGDChronic Granulomatous Disease
Active Not Recruiting
NCT05463133Phase 1/2PrincipalInvestigator

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

Chronic Granulomatous Disease
Recruiting
NCT03910452Early Phase 1PrincipalInvestigator

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Chronic Granulomatous Disease
Active Not Recruiting
NCT01123499PrincipalInvestigator

Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers

Normal Physiology
Terminated
NCT02629120Phase 1/2PrincipalInvestigator

High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

Chronic Granulomatous Disease Transplant
Active Not Recruiting
NCT02116764PrincipalInvestigator

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

Chronic Granulomatous Disease
Completed
NCT01851460Phase 1PrincipalInvestigator

Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease

Chronic Granulomatous Diseases (CGD) and Liver Lesions
Withdrawn
NCT00394316Early Phase 1PrincipalInvestigator

Gene Therapy for Chronic Granulomatous Disease

Chronic Granulomatous Disease
Terminated
NCT00426517Early Phase 1PrincipalInvestigator

Donor Stem Cell Transplantation for Congenital Immunodeficiencies

Inherited Immune Deficiencies
Completed
NCT02282904Phase 1/2PrincipalInvestigator

Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide

Chronic Granulomatous Disease
Terminated

All 13 trials loaded